Tackling Two Orthopedic Risk Factors: Smoking and Obesity
Two investigational drugs are progressing through the regulatory pipeline with notable promise, aiming to address two of the most persistent and impactful comorbidities in orthopedic medicine: smoking and obesity. These conditions are frequently associated with increased perioperative risks, delayed healing, and suboptimal surgical outcomes.